Position in ZTS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$236
-$15,490 QoQ
Shares Held
2
-98.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Westside Investment Management, Inc. holds $25,431,955 across 11 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ETON |
Eton Pharmaceuticals, Inc.
|
431,160 | $15,607,992 | |
| 2 | HROW |
Harrow, Inc.
|
224,051 | $9,515,445 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
5,000 | $169,400 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
4,595 | $66,581 | |
| 5 | VTRS |
Viatris Inc
|
2,130 | $33,823 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,500 | $15,000 | |
| 7 | HLN |
Haleon plc
|
818 | $7,631 | |
| 8 | CRON |
Cronos Group Inc.
|
2,600 | $7,228 |
All Filings in ZTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $236 | 2 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $15,726 | 125 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $28,386 | 194 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $18,558 | 119 | Shares | Sole | 2025-08-05 | |
| 2022-03-31 | $4,526 | 24 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $5,856 | 24 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,659 | 24 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $4,472 | 24 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $3,779 | 24 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $3,972 | 24 | Shares | Sole | 2021-01-15 | |
| No filing history on record for this holder in this stock. | ||||||